Investigator Perspectives
Treatment Advances in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
December 12th 2023Neal Shore, MD, FACS, provides comprehensive insights on the evolving treatment landscape for patients with BCG-unresponsive non-muscle-invasive bladder cancer, with a focus on clinical research and treatment practices.
The Role of Rectal Spacers in the Treatment of Prostate Cancer
October 25th 2023Daniel Allan Hamstra, MD, PhD, FASTRO, FASCO, details the currently available options for rectal spacers in patients with prostate cancer undergoing radiation therapy, and highlights the key clinical trial data leading to their approval for reducing toxicities and preserving sexual quality-of-life.
Genetic Testing in Prostate Cancer: Evidence from Real-World Data on Decipher
May 23rd 2023Expert urologist Michael S. Leapman, MD, MHS, considers how the Decipher Prostate Genomic Classifier and real-world data updates from the 2023 American Urological Association (AUA) Annual Meeting have impacted prostate cancer care.
High-Risk, Non-Muscle-Invasive Bladder Cancer: Recent Updates to KEYNOTE-057 Trial Data
May 22nd 2023Eric A. Singer, MD, MA, FACS, an expert urologic oncologist, discusses recent data from KEYNOTE-057 presented at the 2023 American Urological Association (AUA) Annual Meeting, and offers clinical insights on treatment paradigms for non-muscle-invasive bladder cancer.
